Perspective Therapeutics (CATX)

Perspective Therapeutics (CATX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CATX last traded at $0.87, -1.11% on the day.
• Perspective Therapeutics: P/E -0.6, revenue $656.00K over the last four quarters.
• Over the past year CATX returned -62.65%; year to date -68.36%.

Updated 2026-11-05 12:52 UTC